Clinical Trials Directory

Trials / Unknown

UnknownNCT05344794

Relationship Between Serum N/OFQ and Brain-heart Syndrome

Relationship Between Serum N/OFQ and Cerebral Cardiac Syndrome After Stroke

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Zheng Guo · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Choosing the neurology patients in the Second Hospital of Shanxi Medical University, diagnosed with patients with cerebral syndrome into the experimental group; patients who did not have cerebral syndrome included in the control group, and all selected people had no intimate relationship with each other.Specimen collecting control group and the study group serum inflammatory factor IL-6, solvent peptide and catecholamine content. The difference between the two groups of data was observed.According to the literature, it is guess: The solitary peptide content of the experimental group will be higher than the control group, and is positively correlated with IL-6, catecholamine content.The difference was statistically significant.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEnzyme-linked immunosorbent assaySerum N/OFQ , IL-6 and NE levels were detected.

Timeline

Start date
2023-05-01
Primary completion
2023-09-30
Completion
2023-10-31
First posted
2022-04-25
Last updated
2023-02-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05344794. Inclusion in this directory is not an endorsement.